Literature DB >> 5114631

Evaluation of cell damage in immune reactions by release of radioactivity from 3 H-uridine labeled cells.

Y Hashimoto, H Sudo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5114631

Source DB:  PubMed          Journal:  Gan        ISSN： 0016-450X


× No keyword cloud information.
  9 in total

1.  Preferential generation of killer or helper T-lymphocyte activity directed to the tumour-associated transplantation antigens.

Authors:  H Fujiwara; T Hamaoka; K Teshima; H Aoki; M Kitagawa
Journal:  Immunology       Date:  1976-08       Impact factor: 7.397

2.  Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2.

Authors:  T Nishimura; Y Togashi; M Goto; H Yagi; Y Uchiyama; Y Hashimoto
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Prognostic value of non-MHC-restricted killer cell activity in lung cancer.

Authors:  A M Malygin; A A Redjko; O N Pogodina; N A Karaseva; Y F Koval; T Timonen
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

4.  Significance of the proline assay in the study of anti-MSV cell-mediated immune reactions.

Authors:  Y Henin; E Gomard; S Gisselbrecht; J P Levy
Journal:  Br J Cancer       Date:  1979-01       Impact factor: 7.640

5.  Adhesion molecules on murine lymphokine-activated killer cells responsible for target cell killing: a role of CD2.

Authors:  K Kato; T Tanabe; H Yagita; T Agatsuma; H Hojo; Y Hashimoto
Journal:  Jpn J Cancer Res       Date:  1991-10

6.  Regulatory functions of hapten-reactive helper and suppressor T lymphocytes. III. Amplification of a generation of tumor-specific killer T-lymphocyte activities by suppressor T-cell-depleted hapten-reactive T lymphocytes.

Authors:  T Hamaoka; H Fujiwara; K Teshima; H Aoki; H Yamamoto; M Kitagawa
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

7.  Autologous enhancement by interferon of natural killer activity of human peripheral blood lymphocytes.

Authors:  S B Cheknev; Y G Ashmanova; A D Pritsker; O L Latysheva; F I Yershov; A J Kulberg
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

8.  Establishment of mouse lymphokine-activated killer cell clones and their properties.

Authors:  K Kato; N Sato; T Tanabe; H Yagita; T Agatsuma; Y Hashimoto
Journal:  Jpn J Cancer Res       Date:  1991-04

9.  Augmentation by tumor necrosis factor alpha of the systemic therapeutic effect of lymphokine-activated killer cells in adoptive immunotherapy of murine tumor.

Authors:  K Kato; T Tanabe; T Agatsuma; S Suzuki; H Nitanai; Y Hashimoto
Journal:  Jpn J Cancer Res       Date:  1991-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.